Compare AbCellera Biologics Inc (ABCL) vs Blackrock Inc (BLK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Blackrock Inc — how do they compare? AbCellera Biologics Inc trades at $7.19 (market cap $2.35B), while Blackrock Inc trades at $1,007.5 (market cap $156.46B). The key difference: Blackrock Inc is far larger — about 66.6× AbCellera Biologics Inc's market cap, and Blackrock Inc pays a 2.27% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | BLK | |
|---|---|---|
Market Cap | $2.35B | $156.46B |
Sector | Health | Financials |
52-Week High | $8.12 | $1.20K |
52-Week Low | $2.78 | $922.90 |
Enterprise Value | $1.99B | $158.28B |
Volume | — | 641,547 |
Dividend Yield | — | 2.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 2.29% on the day, with strong analyst support (82% buy ratings) and a $9.67 consensus price target suggesting 26% upside. The stock shows bullish technical momentum with moving averages supporting the trend, though RSI levels indicate potential overbought conditions. Recent positive developments include a major $876 million collaboration with Jazz Pharmaceuticals and board expansions, offsetting concerns about negative cash flow and profitability metrics.
While ABCL faces significant fundamental challenges with negative margins and cash burn, the company's strong cash position ($626M) and recent strategic partnerships provide runway for growth. The primary investment thesis hinges on successful pipeline development and platform monetization, with risks centered on execution and path to profitability. Wall Street remains optimistic about the long-term platform value despite near-term financial headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Blackrock Inc
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →
